Beatrice Wiafe-Addai Named Candidate for UICC Board of Directors 2026–2028
Zolbetuximab and Immunotherapy Across PD-L1 CPS in Advanced Gastric and GEJ Cancer
Multi-Modal AI May Refine Adjuvant Escalation in High-Risk HR+/HER2− Early Breast Cancer
Meet-URO 33 Study: Bone Metastases, SREs and Bone-Targeted Agents in mRCC
Proton Therapy vs Photon Therapy: Differences, Benefits, and Side Effects
The Big Questions in Cancer Immunotherapy: Can We Build an Immune System Inside the Tumor?
BGT26 Annual Conference with Dr. Nagla Abdel Karim
Fabrice André and Miguel Bronchud Discuss Key Challenges in Precision Cancer Prevention and Immuno-Oncology
